| Cyclo Therapeutics (OTCQB: CTDH) to Present Clinical Trial Data on NPC at the 16th Annual WORLDSymposium |
| |
|
Cyclo Therapeutics (OTCQB: CTDH), a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C (NPC) and Alzheimer’s Disease, is scheduled to present data from its US Phase I clinical trial in NPC at the WORLDSymposium in Orlando, Florida, in February.
Why It Matters: The presentation includes liver biopsy data from the first 8 subjects participating in the Phase I trial. Results show that filipin staining in liver tissue in 5 of 8 subjects had marked reductions in filipin staining after 7 doses of Trappsol® Cyclo™, 2 had moderate reductions, and 1 had a mild reduction as compared to baseline. These are the first results showing that Trappsol® Cyclo™, or any hydroxypropyl beta cyclodextrin product, reduces unesterified cholesterol accumulation in liver tissue of NPC patients.
Co-authors of the presentation are the two Co-Principal Investigators of the Phase I trial, Caroline Hastings, MD, UCSF Benioff Children’s Hospital Oakland, and Benny Liu, MD, also affiliated with UCSF Benioff Children’s Hospital Oakland for this trial and the Alameda Health System also in Oakland, joined by Bryan Hurst, MPhil of Boyd Consultants, UK, and Cyclo Therapeutics’ Chief Scientific Officer and Senior Vice President for Medical Affairs Sharon Hrynkow PhD.
The Backstory: Cyclo Therapeutics, Inc. (OTCQB: CTDH), a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease, just received a buy recommendation and $1.25 price target from ThinkEquity, a division of Fordham Financial Management. The Company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is used to treat Niemann-Pick Disease Type C (NPC), a rare and fatal genetic disease, on a compassionate use basis as well as in three ongoing formal clinical trials. The Company was authorized by the FDA to use Trappsol® Cyclo™ for a late-onset Alzheimer’s Disease (AD) patient under a Compassionate Use Program which began intravenous dosing in May 2018. In October 2019, CTDH announced an agreement with Worldwide Clinical Trials, a leading CRO, to conduct a clinical trial to evaluate safety and efficacy in AD.
Disclosure
Cyclo Therapeutics (OTCQB: CTDH) is a client of RedChip Companies, Inc. CTDH paid RedChip Companies, Inc. a fee of $30,000 per month, beginning in August 2019, for four months of RedChip investor awareness services and consulting services.
|
|
| |
|
| Digital Ally (NASDAQ: DGLY) Announces New Government Contract |
| |
|
Digital Ally (NASDAQ: DGLY) which develops, manufactures and markets advanced video recording products for law enforcement, emergency management, fleet safety and security, announced the recent deployment of its FirstVu HD body-worn cameras, DVM-800 in-car digital audio/video systems and patented VuLink® automatic activation systems for Offutt Air Force Base (Offutt) under a previously awarded federal government contract.
Why It Matters: Located near Omaha, Nebraska, Offutt is the headquarters of the U.S. Strategic Command, the 557th Weather Wing, and the 55th Wing of the Air Combat Command. Over the last several years, Digital Ally has expanded its patented technologies to commercial fleet companies and event security applications. The Company is now a preferred technology partner of NASCAR and has been awarded contracts for the well-known venues such as MetLife Stadium and Arrowhead Stadium.
Key Quote: “This order illustrates what we believe will be an industry-wide trend of law enforcement and government agencies choosing Digital Ally as their total video solution. An important factor in obtaining these orders is the ability to offer our patented VuLink® auto activation system, which allows our digital audio/video cameras, such as the DVM-800, and our body-worn cameras to automatically and simultaneously start recording once either of the devices is activated. This allows multiple recordings of the same event from different perspectives in order to provide a more comprehensive recording of incidents in the field. The automatic activation technology included in our patented VuLink® has quickly become a standard requirement in many requests for proposals.” – Stan Ross, CEO
The Backstory: Lenexa, Kansas-based Digital Ally specializes in the design and manufacturing of the highest quality video recording equipment and video analytic software. Digital Ally pushes the boundaries of technology in industries such as law enforcement, emergency management, commercial fleets, and consumer use. Digital Ally’s complete product solutions include in-car and body cameras, cloud and local management software, and automatic recording technology. These products work seamlessly together and are simple to install and operate. Digital Ally products are sold by domestic direct sales representatives and international distributors worldwide.
Disclosure
Digital Ally, Inc. (DGLY) is a client of RedChip Companies, Inc. DGLY agreed to pay RedChip Companies, Inc., a $7,500 monthly cash fee, beginning in September 2017, for RedChip investor awareness services.
|
|
| |
|
| Genetic Technologies (NASDAQ: GENE) to Commence Sales of Breast Cancer Test In First Quarter 2020 |
| |
|
Genetic Technologies (NASDAQ: GENE) announced the full commissioning of its Australian Laboratory for the provisioning of its third generation breast cancer test with sales to commence in the first quarter of 2020.
Why It Matters: Genetype for Breast Cancer is the world first Genomic test to accurately predict risk of disease by combining the information contained in your DNA with family history and mammography data to create a powerful new tool in the battle with breast cancer. Our tests can accurately identify low risk individuals (as low as 1/5 of average risk) as well as high risk individuals (up to 5 times average risk). Unlike BRCA gene testing which is used to detect the 1 in 400 women who carry this cancer associated genetic mutation, Genetype for Breast Cancer is relevant for the better management of 95% of all Breast cancers which are referred to as sporadic (or non-familial) and is ideally suited to be the first line test in a preventative medical genomic based health system. Our tests are designed to complement current screening and not replace them. By starting testing at the age of 35 Genetype is able to help identify some of the 20% of breast cancers that occur before the age of 50, the age at which government sponsored testing begins. In addition, Genetype’s platform technology is able to help identify interval cancers by the targeted increased screening of high-risk individuals (Interval cancers typically strike between the current 2 yearly screening cycles and may represent as many as 25% of all new cancers).
The Backstory: GENE is a diversified molecular diagnostics company. GENE offers cancer predictive testing and assessment tools to help physicians proactively manage patient health. The Company’s lead products GeneType for Breast Cancer and GeneType for Colorectal Cancer are clinically validated risk assessment tests and are first in class. GENE is developing a pipeline of risk assessment products.
Disclosure
Genetic Technologies (GENE) is a client of RedChip Companies, Inc. GENE agreed to pay RedChip Companies, Inc. a $7,500 monthly cash fee, beginning in March 2019, for six (6) months of RedChip investor awareness services.
|
|
| |
|
| SinglePoint (OCTQB: SING) Signs Distribution Agreement with JTI USA |
| |
|
SinglePoint (OTCQB: SING) signed a new distribution agreement that allows for the expanded footprint of PrimeTime little cigars in North America. The companies will exhibit at the MJBIZCON show in Las Vegas December 11-13, 2019.
Why It Matters: The company recently signed on as a distributor for JTI USA, part of the JT Group of companies, a multibillion-dollar organization with international presence in 130 countries. Initially, SinglePoint will start out by supporting to further drive the distribution and sales of PrimeTime Little Cigars.
Key Quote: “I’m excited and honored to be working with JTI to distribute PrimeTime Little Cigars... The opportunity to work with a global leader in this category is exciting and we are ready to expand Primetime’s U.S. market share with our unique experience in alternative markets. Having placed premium cigars in over 30,000 accounts, we expect this opportunity to be one of our major revenue sources in coming years, and to distribute additional JTI products as we grow this category.” – Greg Lambrecht, CEO
The Backstory: SING invests in and acquires brands and companies that will benefit from injection of growth capital and the sales and marketing expertise of SING. The company portfolio currently includes solar renewables, Hemp and distribution tobacco products. SING is working to grow the company to a multi-national brand
Disclosure
SinglePoint, Inc. (SING) is a client of RedChip Companies, Inc. SING agreed to pay RedChip Companies, Inc. a $10,000 monthly cash fee, beginning in June 2019, for RedChip investor awareness services and consulting services.
|
|
| |
|
| Esports Entertainment (OTCQB: GMBL) Closes $1 Million Private Placement |
| |
|
Esports Entertainment Group (OTCQB: GMBL), a licensed online gambling company with a focus on esports wagering and 18+ gaming, closed the final tranche of its private placement offering in early December, raising gross proceeds of $1 million.
Key Quote: “This is another major milestone for our Company. This financing will allow us to complete initiatives that have been announced over the past several months, as we look towards building our business and our brand in order to return shareholder value.” – Grant Johnson, CEO
The Backstory: GMBL is a licensed online gambling company with a focus on esports wagering and 18+ gaming. Esports Entertainment offers bet exchange style wagering on esports events in a licensed, regulated and secure platform to the global esports audience at vie.gg. In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multi-player mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and the video game industries, and esports. The Company holds a license to conduct online gambling and 18+ gaming on a global basis in Curacao, Kingdom of the Netherlands. The Company maintains offices in Malta and Warsaw, Poland.
Disclosure
Esports Entertainment Group, Inc. (GMBL) is a client of RedChip Companies, Inc. GMBL agreed to pay RedChip Companies, Inc. a $4,000 monthly cash fee, beginning in June 2018, and 225,000 shares of Rule 144 stock for RedChip investor awareness services.
|
|
| |
|
| |
| Quote of the Week |
| |
"Higher returns, of course, come with more risk...the trade off is, yes, you get long-term outperformance ... but the volatility of returns is greater... That's the price you pay if you want exposure to a better-performing asset class."
- Samuel Dedio, Manager of the Artio U.S. Microcap Fund (JMCAX) |
|
|
|
|
|
|
|
| About RedChip |
| |
| RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. |
| |
| RedChip Disclosure |
| |
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures. |
|
| |
|
|
| |
|
|
Copyright © 2019 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.
|
|
|
